KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Royalty Pharma (RPRX) Interest Coverage Ratio (2019 - 2025)

Royalty Pharma (RPRX) has disclosed Interest Coverage Ratio for 7 consecutive years, with 4.12 as the latest value for Q4 2025.

  • Quarterly Interest Coverage Ratio fell 24.98% to 4.12 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 5.07 through Dec 2025, down 11.56% year-over-year, with the annual reading at 5.07 for FY2025, 11.56% down from the prior year.
  • Interest Coverage Ratio hit 4.12 in Q4 2025 for Royalty Pharma, down from 5.37 in the prior quarter.
  • In the past five years, Interest Coverage Ratio ranged from a high of 19.9 in Q2 2021 to a low of 10.28 in Q4 2022.
  • Historically, Interest Coverage Ratio has averaged 5.78 across 5 years, with a median of 5.43 in 2025.
  • Biggest five-year swings in Interest Coverage Ratio: tumbled 414.73% in 2022 and later surged 590.76% in 2025.
  • Year by year, Interest Coverage Ratio stood at 3.27 in 2021, then crashed by 414.73% to 10.28 in 2022, then skyrocketed by 226.18% to 12.97 in 2023, then tumbled by 57.61% to 5.5 in 2024, then dropped by 24.98% to 4.12 in 2025.
  • Business Quant data shows Interest Coverage Ratio for RPRX at 4.12 in Q4 2025, 5.37 in Q3 2025, and 3.06 in Q2 2025.